DWI-Detected Ischemic Lesions after Endovascular Treatment for Cerebral Aneurysms: An Updated Systematic Review and Meta-analysis

References

1. 1.↵
   1. Bond KM,
   2. Brinjikji W,
   3. Murad MH, et al

   . Diffusion-weighted imaging-detected ischemic lesions following endovascular treatment of cerebral aneurysms: a systematic review and meta-analysis. AJNR Am J Neuroradiol 2017;38:304–09 doi:10.3174/ajnr.A4989 pmid:27856436

   Abstract/FREE Full Text
2. 2.↵
   1. Choi SH,
   2. Na DL,
   3. Chung CS, et al

   . Diffusion-weighted MRI in vascular dementia. Neurology 2000;54:83–89 doi:10.1212/wnl.54.1.83 pmid:10636130

   CrossRefPubMed
3. 3.↵
   1. Ihn YK,
   2. Shin SH,
   3. Baik SK, et al

   . Complications of endovascular treatment for intracranial aneurysms: management and prevention. Interv Neuroradiol 2018;24:237–45 doi:10.1177/1591019918758493 pmid:29466903

   CrossRefPubMed
4. 4.↵
   1. Zhao J,
   2. Lin H,
   3. Summers R, et al

   . Current treatment strategies for intracranial aneurysms: an overview. Angiology 2018;69:17–30 doi:10.1177/0003319717700503 pmid:28355880

   CrossRefPubMed
5. 5.↵
   1. Higgins JPT,
   2. Thomas J,
   3. Chandler J, et al.

   , eds. Cochrane Handbook for Systematic Reviews of Interventions. 2nd Edition. Chichester (UK): John Wiley & Sons; 2019
6. 6.↵
   1. Merritt WC,
   2. Berns HF,
   3. Ducruet AF, et al

   . Definitions of intracranial aneurysm size and morphology: a call for standardization. Surg Neurol Int 2021;12:506 doi:10.25259/SNI_576_2021 pmid:34754556

   CrossRefPubMed
7. 7.↵
   1. Duval S,
   2. Tweedie R

   . Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000;56:455–63 doi:10.1111/j.0006-341x.2000.00455.x pmid:10877304

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Shi L,
   2. Lin L

   . The trim-and-fill method for publication bias: practical guidelines and recommendations based on a large database of meta-analyses. Medicine (Baltimore) 2019;98:e15987 doi:10.1097/MD.0000000000015987 pmid:31169736

   CrossRefPubMed
9. 9.↵
   1. Dibas M,
   2. Doheim MF,
   3. Ghozy S, et al

   . Incidence and survival rates and trends of skull base chondrosarcoma: a population-based study. Clin Neurol Neurosurg 2020;198:106153 doi:10.1016/j.clineuro.2020.106153 pmid:32818757

   CrossRefPubMed
10. 10.↵
    1. Ghozy S,
    2. Dibas M,
    3. Afifi AM, et al

    . Primary cerebral lymphoma' characteristics, incidence, survival, and causes of death in the United States. J Neurol Sci 2020;415:116890 doi:10.1016/j.jns.2020.116890 pmid:32428760

    CrossRefPubMed
11. 11.↵
    1. Kim HJ,
    2. Fay MP,
    3. Feuer EJ, et al

    . Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000;19:335–51 doi:10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z pmid:10649300

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Politis M,
    2. Higuera G,
    3. Chang LR, et al

    . Trend analysis of cancer mortality and incidence in Panama, using joinpoint regression analysis. Medicine (Baltimore) 2015;94:e970 doi:10.1097/MD.0000000000000970 pmid:26091467

    CrossRefPubMed
13. 13.↵
    1. Kim HJ,
    2. Chen HS,
    3. Midthune D, et al

    . Data-driven choice of a model selection method in joinpoint regression. J Appl Stat 2023;50:1992–2013 doi:10.1080/02664763.2022.2063265 pmid:37378270

    CrossRefPubMed
14. 14.↵
    1. Wells GA,
    2. Shea B,
    3. O’Connell D, et al

    . The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Clin Epidemiol 2000 https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed July 21, 2022
15. 15.↵
    1. Akgul E,
    2. Onan HB,
    3. Akpinar S, et al

    . The DERIVO Embolization Device in the treatment of intracranial aneurysms: short- and midterm results. World Neurosurg 2016;95:229–40 doi:10.1016/j.wneu.2016.07.101 pmid:27514698

    CrossRefPubMed
16. 16.↵
    1. Biondi A,
    2. Oppenheim C,
    3. Vivas E, et al

    . Cerebral aneurysms treated by Guglielmi detachable coils: evaluation with diffusion-weighted MR imaging. AJNR Am J Neuroradiol 2000;21:957–63 pmid:10815677

    Abstract/FREE Full Text
17. 17.↵
    1. Brasiliense LB,
    2. Stanley MA,
    3. Grewal SS, et al

    . Silent ischemic events after Pipeline Embolization Device: a prospective evaluation with MR diffusion-weighted imaging. J Neurointerv Surg 2016;8:1136–39 doi:10.1136/neurintsurg-2015-012091 pmid:26747877

    Abstract/FREE Full Text
18. 18.↵
    1. Cronqvist M,
    2. Wirestam R,
    3. Ramgren B, et al

    . Diffusion and perfusion MRI in patients with ruptured and unruptured intracranial aneurysms treated by endovascular coiling: complications, procedural results, MR findings and clinical outcome. Neuroradiology 2005;47:855–73 doi:10.1007/s00234-005-1408-2 pmid:16235046

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Grunwald IQ,
    2. Papanagiotou P,
    3. Politi M, et al

    . Endovascular treatment of unruptured intracranial aneurysms: occurrence of thromboembolic events. Neurosurgery 2006;58:612–18 doi:10.1227/01.NEU.0000204101.00996.D9 pmid:16575324

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Heller RS,
    2. Dandamudi V,
    3. Calnan D, et al

    . Neuroform intracranial stenting for aneurysms using simple and multi-stent technique is associated with low risk of magnetic resonance diffusion-weighted imaging lesions. Neurosurgery 2013;73:582–90; discussion 590–91 doi:10.1227/NEU.0000000000000053 pmid:23787881

    CrossRefPubMed
21. 21.↵
    1. Heller RS,
    2. Dandamudi V,
    3. Lanfranchi M, et al

    . Effect of antiplatelet therapy on thromboembolism after flow diversion with the Pipeline Embolization Device. J Neurosurg 2013;119:1603–10 doi:10.3171/2013.7.JNS122178 pmid:23971953

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Iosif C,
    2. Lecomte JC,
    3. Pedrolo-Silveira E, et al

    . Evaluation of ischemic lesion prevalence after endovascular treatment of intracranial aneurysms, as documented by 3-T diffusion-weighted imaging: a 2-year, single-center cohort study. J Neurosurg 2018;128:982–91 doi:10.3171/2016.11.JNS161020 pmid:28598274

    CrossRefPubMed
23. 23.↵
    1. Kim JK,
    2. Choi JH,
    3. Kim BS, et al

    . Association of anterior cerebral artery variants and cerebral infarction in patients with balloon-assisted coil embolization for unruptured internal carotid artery aneurysms. World Neurosurg 2021;147:e69–77 doi:10.1016/j.wneu.2020.11.118 pmid:33253946

    CrossRefPubMed
24. 24.↵
    1. Kim MJ,
    2. Lim YC,
    3. Oh SY, et al

    . Thromboembolic events associated with electrolytic detachment of Guglielmi detachable coils and target coils: comparison with use of diffusion-weighted MR imaging. J Korean Neurosurg Soc 2013;54:19–24 doi:10.3340/jkns.2013.54.1.19 pmid:24044075

    CrossRefPubMed
25. 25.↵
    1. Kim MS,
    2. Jo KI,
    3. Yeon JY, et al

    . Association between postprocedural infarction and antiplatelet drug resistance after coiling for unruptured intracranial aneurysms. AJNR Am J Neuroradiol 2016;37:1099–105 doi:10.3174/ajnr.A4777 pmid:27056423

    Abstract/FREE Full Text
26. 26.↵
    1. Kim SH,
    2. Lee H,
    3. Kim SB, et al

    . Differences in thromboembolism after stent-assisted coiling for unruptured aneurysms between aspirin plus clopidogrel and ticagrelor. J Clin Neurosci 2020;82:128–33 doi:10.1016/j.jocn.2020.10.042 pmid:33317720

    CrossRefPubMed
27. 27.↵
    1. Kono K,
    2. Shintani A,
    3. Yoshimura R, et al

    . Triple antiplatelet therapy with addition of cilostazol to aspirin and clopidogrel for Y-stent-assisted coil embolization of cerebral aneurysms. Acta Neurochir (Wien) 2013;155:1549–57 doi:10.1007/s00701-013-1771-4 pmid:23715948

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Lee SH,
    2. Jang MU,
    3. Kang J, et al

    . Impact of reducing the procedure time on thromboembolism after coil embolization of cerebral aneurysms. Front Neurol 2018;9:1125 doi:10.3389/fneur.2018.01125 pmid:30619075

    CrossRefPubMed
29. 29.↵
    1. Lowe SR,
    2. Bhalla T,
    3. Tillman H, et al

    . A comparison of diffusion-weighted imaging abnormalities following balloon remodeling for aneurysm coil embolization in the ruptured vs unruptured setting. Neurosurgery 2018;82:516–24 doi:10.1093/neuros/nyx240 pmid:28520916

    CrossRefPubMed
30. 30.↵
    1. Matsushige T,
    2. Kiura Y,
    3. Sakamoto S, et al

    . Multiple antiplatelet therapy contributes to the reversible high signal spots on diffusion-weighted imaging in elective coiling of unruptured cerebral aneurysm. Neuroradiology 2013;55:449–57 doi:10.1007/s00234-013-1137-x pmid:23314799

    CrossRefPubMed
31. 31.↵
    1. Nakae R,
    2. Nagaishi M,
    3. Kawamura Y, et al

    . Microhemorrhagic transformation of ischemic lesions on T2*-weighted magnetic resonance imaging after Pipeline Embolization Device treatment. J Neurosurg 2018 May 1 [Epub ahead of print] doi:10.3171/2017.12.JNS172480 pmid:29999443

    CrossRefPubMed
32. 32.↵
    1. Park JC,
    2. Lee DH,
    3. Kim JK, et al

    . Microembolism after endovascular coiling of unruptured cerebral aneurysms: incidence and risk factors. J Neurosurg 2016;124:777–83 doi:10.3171/2015.3.JNS142835 pmid:26381257

    CrossRefPubMed
33. 33.↵
    1. Petrov A,
    2. Rentsenkhuu G,
    3. Nota B, et al

    . Initial experience with the novel p64MW HPC flow diverter from a cohort study in unruptured anterior circulation aneurysms under dual antiplatelet medication. Interv Neuroradiol 2021;27:42–50 doi:10.1177/1591019920939845 pmid:32640858

    CrossRefPubMed
34. 34.↵
    1. Pikis S,
    2. Mantziaris G,
    3. Mamalis V, et al

    . Diffusion weighted image documented cerebral ischemia in the postprocedural period following Pipeline Embolization Device with shield technology treatment of unruptured intracranial aneurysms: a prospective, single center study. J Neurointerv Surg 2020;12:407–11 doi:10.1136/neurintsurg-2019-015363 pmid:31558655

    Abstract/FREE Full Text
35. 35.↵
    1. Platz J,
    2. Wagner M,
    3. Güresir E, et al

    . Early diffusion-weighted MRI lesions after treatment of unruptured intracranial aneurysms: a prospective study. J Neurosurg 2017;126:1070–78 doi:10.3171/2016.2.JNS152456 pmid:27203140

    CrossRefPubMed
36. 36.↵
    1. Sim SY,
    2. Shin YS

    . Silent microembolism on diffusion-weighted MRI after coil embolization of cerebral aneurysms. Neurointervention 2012;7:77–84 doi:10.5469/neuroint.2012.7.2.77 pmid:22970416

    CrossRefPubMed
37. 37.↵
    1. Soeda A,
    2. Sakai N,
    3. Sakai H, et al

    . Thromboembolic events associated with Guglielmi detachable coil embolization of asymptomatic cerebral aneurysms: evaluation of 66 consecutive cases with use of diffusion-weighted MR imaging. AJNR Am J Neuroradiol 2003;24:127–32 pmid:12533341

    PubMedWeb of Science
38. 38.↵
    1. Son W,
    2. Kang DH

    . Risk factor analysis of delayed intracerebral hemorrhage after coil embolization of unruptured cerebral aneurysms. Front Neurol 2020;11:584596 doi:10.3389/fneur.2020.584596 pmid:33193045

    CrossRefPubMed
39. 39.↵
    1. Takigawa T,
    2. Suzuki K,
    3. Sugiura Y, et al

    . Thromboembolic events associated with single balloon-, double balloon-, and stent-assisted coil embolization of asymptomatic unruptured cerebral aneurysms: evaluation with diffusion-weighted MR imaging. Neuroradiology 2014;56:1079–86 doi:10.1007/s00234-014-1421-4 pmid:25185529

    CrossRefPubMed
40. 40.↵
    1. Tan LA,
    2. Keigher KM,
    3. Munich SA, et al

    . Thromboembolic complications with Pipeline Embolization Device placement: impact of procedure time, number of stents and pre-procedure P2Y12 reaction unit (PRU) value. J Neurointerv Surg 2015;7:217–21 doi:10.1136/neurintsurg-2014-011111 pmid:24553344

    Abstract/FREE Full Text
41. 41.↵
    1. Tokunaga K,
    2. Hatano T,
    3. Nakahara I, et al

    . Factors associated with postprocedural diffusion-weighted imaging-positive lesions in endovascular treatment for unruptured cerebral aneurysms. World Neurosurg 2019;130:e457–62 doi:10.1016/j.wneu.2019.06.114 pmid:31247348

    CrossRefPubMed
42. 42.↵
    1. Yang H,
    2. Li Y,
    3. Jiang Y, et al

    . Thromboelastography for monitoring platelet function in unruptured intracranial aneurysm patients undergoing stent placement. Interv Neuroradiol 2015;21:61–68 doi:10.15274/inr-2014-10094 pmid:25934777

    CrossRefPubMed
43. 43.↵
    1. Altay T,
    2. Kang HI,
    3. Woo HH, et al

    . Thromboembolic events associated with endovascular treatment of cerebral aneurysms. J Neurointerv Surg 2011;3:147–50 doi:10.1136/jnis.2010.003616 pmid:21990807

    Abstract/FREE Full Text
44. 44.↵
    1. Iosif C,
    2. Camilleri Y,
    3. Saleme S, et al

    . Diffusion-weighted imaging-detected ischemic lesions associated with flow-diverting stents in intracranial aneurysms: safety, potential mechanisms, clinical outcome, and concerns. J Neurosurg 2015;122:627–36 doi:10.3171/2014.10.JNS132566 pmid:25559933

    CrossRefPubMed
45. 45.↵
    1. Mohammad Seyedsaadat S,
    2. Rangel Castilla L,
    3. Lanzino G, et al

    . Remote ischemic preconditioning for elective endovascular intracranial aneurysm repair: a feasibility study. Neuroradiol J 2019;32:166–72 doi:10.1177/1971400919842059 pmid:30942660

    CrossRefPubMed
46. 46.↵
    1. Lee SH,
    2. Kim SH,
    3. Jang JH, et al

    . Diffusion-weighted imaging-positive lesions following endovascular treatment for ruptured and unruptured aneurysms: its incidence according to antithrombotic drugs. J Cerebrovasc Endovasc Neurosurg 2022;24:249–56 doi:10.7461/jcen.2022.E2022.01.002 pmid:36065468

    CrossRefPubMed
47. 47.↵
    1. Kang DH,
    2. Kim BM,
    3. Kim DJ, et al

    . MR-DWI-positive lesions and symptomatic ischemic complications after coiling of unruptured intracranial aneurysms. Stroke 2013;44:789–91 doi:10.1161/STROKEAHA.112.669853 pmid:23204052

    Abstract/FREE Full Text
48. 48.↵
    1. Edwards NJ,
    2. Jones WH,
    3. Sanzgiri A, et al

    . Antiplatelet therapy for the prevention of peri-coiling thromboembolism in high-risk patients with ruptured intracranial aneurysms. J Neurosurg 2017;127:1326–32 doi:10.3171/2016.9.JNS161340 pmid:28059659

    CrossRefPubMed